BACKGROUND: Although the incidence and prevalence of dementia associated with human immunodeficiency virus (HIV) infection has decreased since the introduction of highly active antiretroviral therapy, cognitive dysfunction remains one of the most prevalent factors severely affecting quality of life in patients with HIV. Previous magnetic resonance imaging (MRI) studies showed a correlation between brain atrophy, enlargement of the ventricles and cognitive impairment in HIV patients. OBJECTIVE: To investigate the usefulness of transcranial sonographic (TCS) measurement of the third ventricle in detection of brain atrophy in HIV patients and the correlation with neuropsychological deficits. METHODS: We examined 47 HIV patients and 40 healthy age-matched controls with TCS, neuroimaging (cranial MRI or computed tomography) and a neuropsychological test battery. RESULTS: The third ventricle was significantly larger in patients than in healthy controls and correlated significantly with duration of HIV, Center of Disease Control (CDC) stage, CD4 lymphocytes and distinct cognitive and motor deficits. CONCLUSION: TCS cannot replace neuroimaging but is a valuable method in the detection of brain atrophy and follow-up of HIV patients at risk or with a recent diagnosis of HIV encephalopathy.
BACKGROUND: Although the incidence and prevalence of dementia associated with human immunodeficiency virus (HIV) infection has decreased since the introduction of highly active antiretroviral therapy, cognitive dysfunction remains one of the most prevalent factors severely affecting quality of life in patients with HIV. Previous magnetic resonance imaging (MRI) studies showed a correlation between brain atrophy, enlargement of the ventricles and cognitive impairment in HIVpatients. OBJECTIVE: To investigate the usefulness of transcranial sonographic (TCS) measurement of the third ventricle in detection of brain atrophy in HIVpatients and the correlation with neuropsychological deficits. METHODS: We examined 47 HIVpatients and 40 healthy age-matched controls with TCS, neuroimaging (cranial MRI or computed tomography) and a neuropsychological test battery. RESULTS: The third ventricle was significantly larger in patients than in healthy controls and correlated significantly with duration of HIV, Center of Disease Control (CDC) stage, CD4 lymphocytes and distinct cognitive and motor deficits. CONCLUSION:TCS cannot replace neuroimaging but is a valuable method in the detection of brain atrophy and follow-up of HIVpatients at risk or with a recent diagnosis of HIV encephalopathy.
Authors: N Sacktor; R L Skolasky; P M Tarwater; J C McArthur; O A Selnes; J Becker; B Cohen; B Visscher; E N Miller Journal: Neurology Date: 2003-08-26 Impact factor: 9.910
Authors: N Sacktor; R H Lyles; R Skolasky; C Kleeberger; O A Selnes; E N Miller; J T Becker; B Cohen; J C McArthur Journal: Neurology Date: 2001-01-23 Impact factor: 9.910
Authors: Sohil H Patel; Dennis L Kolson; Guila Glosser; Isabel Matozzo; Yulin Ge; James S Babb; Lois J Mannon; Robert I Grossman Journal: AJNR Am J Neuroradiol Date: 2002-04 Impact factor: 3.825
Authors: E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur Journal: Neurology Date: 1999-02 Impact factor: 9.910
Authors: G Schifitto; M P McDermott; J C McArthur; K Marder; N Sacktor; D R McClernon; K Conant; B Cohen; L G Epstein; K Kieburtz Journal: Neurology Date: 2005-03-08 Impact factor: 9.910
Authors: G J Dal Pan; J H McArthur; E Aylward; O A Selnes; T E Nance-Sproson; A J Kumar; E D Mellits; J C McArthur Journal: Neurology Date: 1992-11 Impact factor: 9.910